Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;20(1):135-7.
doi: 10.3201/eid2001.130732.

Drug-resistant tuberculosis in high-risk groups, Zimbabwe

Drug-resistant tuberculosis in high-risk groups, Zimbabwe

John Z Metcalfe et al. Emerg Infect Dis. 2014 Jan.

Abstract

To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.

Keywords: HIV/TB; MDR TB; Mycobacterium tuberculosis; Zimbabwe; antimicrobial resistance; bacteria; drug-resistant tuberculosis; mycobacteria; retreatment tuberculosis; tuberculosis.

PubMed Disclaimer

References

    1. World Health Organization. Multidrug and extensively drug-resistant tuberculosis: 2010 global report on surveillance and response. Geneva: The Organization; 2010. [cited 2013 Aug 22]. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
    1. World Health Organization. Global tuberculosis report 2012. [cited 2013 Jul 28]. http://www.who.int/tb/publications/global_report/en
    1. Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet. 2010;376:1244–53. 10.1016/S0140-6736(10)61425-0 - DOI - PMC - PubMed
    1. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010. Bull World Health Organ. 2012;90:111–9D. - PMC - PubMed
    1. Marais BJ, Mlambo CK, Rastogi N, Zozio T, Duse AG, Victor TC, et al. Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J Clin Microbiol. 2013;51:1818–25. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources